Healthcare
HUTCHMED (China) Limited
HCM$14.11+17.19%
Price is delayed.
Add to Watchlist
About HUTCHMED (China) Limited
HUTCHMED discovers and develops drugs to treat cancer and immune system diseases. The company makes several cancer medicines that work by targeting specific proteins in the body that fuel tumor growth or help the immune system fight cancer. They sell these drugs internationally and work with major pharmaceutical companies like AstraZeneca and Eli Lilly to develop and commercialize their treatments.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore